Board Certifications: Radiation Oncology
Languages: English
Locations: Hackensack, NJ
Brett Lewis, MD, PhD, is an authority on the use of radiation therapy to treat cancer, including highly targeted external radiation techniques as well as internal approaches (brachytherapy). He is also involved in research to evaluate new radiation therapy regimens and methods, with the goal of improving treatment effectiveness while reducing side effects. He brings with him an undergraduate major in physics (with High Honors) and graduate school expertise in physical biochemistry. He is the first author on most of his publications, with articles in a number of different journals, including Medical Physics, Journal of Clinical Oncology, and Journal of the American Chemical Society. Dr. Lewis wrote a book chapter on isotope effects in biochemistry and worked behind the scenes on radiation exposure research with NASA. He has taught learners at many levels. With a short interlude as Clinical Assistant Professor in Radiation Oncology at University of North Carolina-Chapel Hill, he has lived in the New York metropolitan area since 1994. He has worked at several other hospitals in the area and is especially proud to be a member of the remarkable teams at John Theurer Cancer Center and Hackensack University Medical Center.
Jersey’s Best Magazine Top Doctors: 2024
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.